InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Gilead Sciences

GILD Clue Score57
United States Fiscal year ends December CIK 0000882095 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

30
Insider
Date
Role
Action
Shares
Price
Amount
Daniel Patrick O'Day
30 Oct 2026
Chairman & CEO
Sold after exercise
15,881
$175.25
$2.78M
Anthony Welters
26 Aug 2026
Director
Sold after exercise
6,880
$148.82
$1.02M
Anthony Welters
26 Aug 2026
Director
Sold after exercise
3,402
$148.24
$504.30K
Anthony Welters
26 Aug 2026
Director
Sold after exercise
4,600
$148.82
$684.59K
Anthony Welters
26 Aug 2026
Director
Sold after exercise
3,118
$148.31
$462.43K
Jeffrey Bluestone
20 Aug 2026
Director
Sold after exercise
335
$146.26
$49.00K
Jeffrey Bluestone
20 Aug 2026
Director
Sold after exercise
26
$146.36
$3.81K
Jeffrey Bluestone
20 Aug 2026
Director
Sold after exercise
1,658
$145.73
$241.62K
Jeffrey Bluestone
20 Aug 2026
Director
Sold after exercise
1,816
$144.92
$263.18K
Jeffrey Bluestone
20 Aug 2026
Director
Sold after exercise
1,165
$143.75
$167.47K
Johanna Mercier
17 Aug 2026
Chief Comm & Corp Aff Officer
Sold after exercise
11,470
$138.04
$1.58M
Johanna Mercier
17 Aug 2026
Chief Comm & Corp Aff Officer
Sold after exercise
16,530
$137.37
$2.27M
Johanna Mercier
15 May 2026
Chief Comm & Corp Aff Officer
Sold after exercise
700
$132.75
$92.93K
Johanna Mercier
15 May 2026
Chief Comm & Corp Aff Officer
Sold after exercise
8,374
$132.23
$1.11M
Johanna Mercier
15 May 2026
Chief Comm & Corp Aff Officer
Sold after exercise
11,177
$131.19
$1.47M
Johanna Mercier
15 May 2026
Chief Comm & Corp Aff Officer
Sold after exercise
7,749
$130.29
$1.01M
Johanna Mercier
17 Feb 2026
Chief Comm & Corp Aff Officer
Sold after exercise
200
$155.62
$31.12K
Johanna Mercier
17 Feb 2026
Chief Comm & Corp Aff Officer
Sold after exercise
9,395
$154.91
$1.46M
Johanna Mercier
17 Feb 2026
Chief Comm & Corp Aff Officer
Sold after exercise
18,405
$154.18
$2.84M
Daniel Patrick O'Day
5 Feb 2026
Chairman & CEO
Sold after exercise
115,640
$150.00
$17.35M
Daniel Patrick O'Day
23 Jan 2026
Chairman & CEO
Sold after exercise
115,640
$135.00
$15.61M
Jeffrey Bluestone
20 Jan 2026
Director
Sold after exercise
5,000
$123.50
$617.50K
Kelly A. Kramer
28 Nov 2025
Director
Sold after exercise
2,805
$127.10
$356.52K
Jeffrey Bluestone
28 Nov 2025
Director
Sold after exercise
5,000
$125.08
$625.40K
Kelly A. Kramer
26 Nov 2025
Director
Sold after exercise
2,806
$127.11
$356.67K
Johanna Mercier
17 Nov 2025
Chief Commercial Officer
Sold after exercise
2,476
$126.26
$312.61K
Johanna Mercier
17 Nov 2025
Chief Commercial Officer
Sold after exercise
25,524
$125.83
$3.21M
Deborah H Telman
12 Nov 2025
EVP, Corporate Affairs & GC
Sold after exercise
500
$122.90
$61.45K
Deborah H Telman
12 Nov 2025
EVP, Corporate Affairs & GC
Sold after exercise
35,965
$122.30
$4.40M
Deborah H Telman
12 Nov 2025
EVP, Corporate Affairs & GC
Sold after exercise
17,181
$124.00
$2.13M
Show all 83 transactions →

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 0
Filings about a different issuer 3
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 53
Sales straight out of an exercise 30
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,024,527
History held since 29 Sep 2006